Exchange to reply to FMC's letter soon, CEO says buyers can't be declared defaulters where there is 'market disruption'.
Brokers have only kept guarantees for which they have open positions.
Imports in July 2012 were 65 tonnes, said a bullion analyst.
Govt restrictions on import biting deep; trade petitions for relief with units, workers idling.
Ratio trading in gold and silver prices is a trading tool.
The Dragon is likely to be a prominent discussion topic, as PM begins his three-day Japan visit, reports Shyamal Majumdar
However, other commodities yet to see meaningful recovery in global markets
Gems & jewellery exports seen rising, too, as demand remains strong in all markets except Europe.
Most companies still treat exit interviews as a fuzzy exercise It's your last day, actually hour, in the office.
Make no mistake, EQ is central to success in leadership and not just a touchy-feely trend.
The yellow metal has risen 6.6 per cent since mid-August
Companies now look at the adversity quotient scores of their leaders.
The 'outsider' CEO of India's fifth largest pharma company says working in a family-owned outfit has been an unexpectedly easy ride.
Anil Sardana, managing director of India's largest private power producer, says though the tariff freeze by some states is causing tremendous stress, the company will go ahead with the expansion of the Mundra project.
The sales growth rate has been a 10-quarter low, dragged by slowdown in the key sectors -- capital goods, construction, infrastructure, non ferrous metals, steel and telecom -- that had contributed to India Inc's growth story in the past.
Sharp rupee fall, interest differential on export finance rates may have led to arbitrage in gold.
Earlier expectations of gold imports touching 1,000 tonnes in 2011 have been belied, with a steep fall in imports in recent months.
The board has decided to expand into all financial services for the rural population. SKS would, however, continue to be a strong player in the microfinance business. Financial inclusion would continue to be in the centre of our activities.
While domestic sales in the second quarter are expected to be weak for major players, Lupin is likely to outperform the pharma sector on the back of a growing chronic portfolio.
Sebi panel to revisit norms for IPOs, mutual funds.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances